Is there an afterlife? Science can prove there is, quantum physicist claims

Is there an afterlife? Science can prove there is, quantum physicist claims
Professor Robert Lanza says biocentrism explains that the universe only exists because of an individual’s consciousness of it — essentially life and biology are central to reality, which in turn creates the universe; the universe itself does not create life.
LONDON: It's a question pondered by philosophers, scientists and the devout since the dawn of time: is there an afterlife?

While the religious would argue that life on earth is a mere warm up for an eternity spent in heaven or hell, and many scientists would dismiss the concept for lack of proof — one expert claims he has definitive evidence to confirm once and for all that there is indeed life after death.

The answer, Professor Robert Lanza says, lies in quantum physics — specifically the theory of biocentrism. The scientist, from Wake Forest University School of Medicine in North Carolina, says the evidence lies in the idea that the concept of death is a mere figment of our consciousness.

Professor Lanza says biocentrism explains that the universe only exists because of an individual's consciousness of it — essentially life and biology are central to reality, which in turn creates the universe; the universe itself does not create life. The same applies to the concepts of space and time, which Professor Lanza describes as "simply tools of the mind".

In a message posted on the scientist's website, he explains that with this theory in mind, the concept of death as we know it is "cannot exist in any real sense" as there are no true boundaries by which to define it. Essentially, the idea of dying is something we have long been taught to accept, but in reality it just exists in our minds.

Professor Lanza says biocentrism is similar to the idea of parallel universes — a concept hypothesised by theoretical physicists. In much the same way as everything that could possibly happen is speculated to be occurring all at once across multiple universes, he says that once we begin to question our preconceived concepts of time and consciousness, the alternatives are huge and could alter the way we think about the world in a way not seen since the 15th century's "flat earth" debate.

He goes on to use the so-called double-slit experiment as proof that the behaviour of a particle can be altered by a person's perception of it. In the experiment, when scientists watch a particle pass through a multi-holed barrier, the particle acts like a bullet travelling through a single slit. When the article is not watched, however, the particle moves through the holes like a wave.

Scientists argue that the double-slit experiment proves that particles can act as two separate entities at the same time, challenging long-established ideas of time and perception.

Although the idea is rather complicated, Professor Lanza says it can be explained far more simply using colours. Essentially, the sky may be perceived as blue, but if the cells in our brain were changed to make the sky look green, was the sky every truly blue or was that just our perception?

In terms of how this affects life after death, Professor Lanza explains that, when we die, our life becomes a "perennial flower that returns to bloom in the multiverse". He added: "Life is an adventure that transcends our ordinary linear way of thinking. When we die, we do so not in the random billiard-ball-matrix but in the inescapable-life-matrix."

Professor Lanza's theory is explained in full in his book Biocentrism: How Life and Consciousness are the Keys to Understanding the True Nature of the Universe.

'robot suicide',[SOON MURDER BY ROBOT NEWS]


Robot kills itself over tedious household chores!


Robot kills itself over tedious household chores!
LONDON: In what is being touted as the world's first case of 'robot suicide', a house bot fed up of its tedious job of cleaning has ended its life by climbing onto a kitchen hotplate and destroying itself in a blaze.
The android in an Austrian household had to clean up some spilt cereal when it climbed onto a kitchen hotplate and was destroyed.
It had grown tired of being forced to clean the same house every day, according to reports in Austria.
"Somehow it seems to have reactivated itself and made its way along the work surface where it pushed a cooking pot out of the way and basically that was the end of it," explained fireman Helmut Kniewasser, who was called to tackle the blaze at Hinterstoder in Kirchdorf, Austria.
"It pretty quickly started to melt underneath and then stuck to the kitchen hotplate. It then caught fire. By the time we arrived, it was just a pile of ash," Kniewasser said.
The entire building had to be evacuated and there was severe smoke damage particularly in the flat where the robot had been in use, 'metro.co.uk' reported.
"It's a mystery how it came to be activated and ended up making its way to the hotplate. I don't know about the allegations of a robot suicide but the homeowner is insistent that the device was switched off," Kniewasser said.
The homeowner plans to sue the robot's manufacturer.

New drug combo causes cancer cells to 'eat themselves'


WASHINGTON: A new drug combination therapy could effectively kill colon, liver, lung, kidney, breast and brain cancer cells without affecting the healthy cells, scientists say.

The results from a recent preclinical study at Virginia Commonwealth University Massey Cancer Center lays the foundation to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.

"It is still too premature to estimate when a clinical trial will open to further test this drug combination therapy, but we are now in the planning phase and encouraged by the results of these laboratory experiments," said Andrew Poklepovic, assistant professor in the Division of Hematology, Oncology and Palliative Care at VCU School of Medicine.

The study led by Paul Dent demonstrated that the drugs sorafenib and regorafenib synergise with a class of drugs known as PI3K/AKT inhibitors to kill a variety of cancers.

Sorafenib and regorafenib work by blocking the production of enzymes called kinases, which are vital to the growth and survival of cancer cells.

Sorafenib is currently approved by the FDA to treat kidney and liver cancers, and regorafenib is currently approved for the treatment of colorectal cancer.

However, sorafenib and regorafenib do not directly affect PI3K and AKT kinases, which are also very active in promoting cancer cell survival.

The addition of a PI3K/AKT inhibitor to the combination of sorafenib and regorafenib dramatically increased cell death and was even effective against cells with certain mutations that make one or the other drug less effective.

"We know that there are certain cellular processes that are frequently dysregulated in cancers and important to cell proliferation and survival, but if you shut down one, then cells can often compensate by relying on another," said Dent.

"We are blocking several of these survival pathways, and the cancer cells are literally digesting themselves in an effort to stay alive," Dent said.

Results showed that the combination therapy killed the cells by physically interacting with molecules to block the survival pathways and induce a toxic effect known as autophagy.

Autophagy is a protective process where cells metabolise themselves when starved of the resources needed to survive.

The study was published in the journal Molecular Pharmacology.